feedback

Course Director

Mark S. Freedman, MD
Mark S. Freedman, MD

University of Ottawa
Ottawa, Ontario, Canada

Accredited by

Medical Learning Institute, Inc.

View Activity Materials

Activity Details

Credit Types:CME
Credit Amount:0.25 Credits
Release Date:2017-Aug-21
Expiration Date:2018-Aug-20
Estimated Time for Completion:15 minutes
Registration Required:No
Cost:Free of Charge

Activity Description and Educational Objectives

In this activity, an expert in neurology discusses the effectiveness of disease-modifying therapies in treating patients with multiple sclerosis.

Upon completion of this activity, participants should be better able to:
  • Apply key data sets from head-to-head clinical trials of approved disease-modifying therapies when managing patients with multiple sclerosis
  • Develop strategies to incorporate number needed to treat analyses on approved disease-modifying therapies when making treatment decisions for individuals with multiple sclerosis

Target Audience

This activity has been designed to meet the educational needs of neurologists and other clinicians involved in multiple sclerosis.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: August 21, 2017 - August 20, 2018
Time to Complete: 15 minutes

Faculty & Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME activity during the past 12 months.

Course Director

Mark S. Freedman, MD
Professor of Neurology
University of Ottawa
Ottawa, Ontario, Canada

Mark S. Freedman, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Actelion Pharmaceuticals Ltd; Bayer Inc.; Biogen Canada Inc.; Chugai Pharmaceutical Co., Ltd.; EMD Serono Canada Inc.; Genzyme Canada Inc.; Hoffmann-La Roche Limited; Merck Serono; Novartis Pharmaceuticals Canada Inc.; Sanofi; and Teva Canada Innovation.
Grant/Research Support from Genzyme Canada Inc.
Speakers Bureau participant with Genzyme Canada Inc.
Other Financial or Material Support from Actelion Pharmaceuticals Ltd; Bayer Inc.; Biogen Canada Inc.; Hoffmann-La Roche Limited; MedDay; Merck Serono; Novartis Pharmaceuticals Canada Inc.; and Sanofi in the form of advisory panels and steering committees for trials.
Mark S. Freedman, MD, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.

CME Reviewer

Randy M. Rosenberg, MD, FACP, FAAN
Assistant Professor of Neurology
Temple University School of Medicine
Philadelphia, Pennsylvania

Randy M. Rosenberg, MD, FACP, FAAN, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Kirk A. Tacka, PhD
PVI, PeerView Institute for Medical Education

Kirk A. Tacka, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Providership

This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by an educational grant from Sanofi Genzyme.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

For approved prescribing information, please consult the manufacturer’s product labeling. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our activities. No responsibility is taken for errors or omissions in activities.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.

About This CME Activity

PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.

Copyright © 2000-2017, PeerView Press

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.